Financial Highlights | Lee's Pharmaceutical

Investors

Fact Sheet

Financial Highlights

Year ended 31 December
HK$'000
2020
2019
Changes
Revenue
1,216,716
1,218,913
- 0.2%
Gross Profit
781,066
798,256
- 2.2%
Gross Profit Margin (%)
64.2%
65.5%
- 1.3pp
EBITDA
266,728
223,907
+19.1%
Profit from Operations
151,923
141,405
+7.4%
Profit attributable to shareholders of the Company
129,316
125,553
+3.0%
Basic EPS
HK 21.99 cents
HK 21.22 cents
+3.6%
Diluted EPS
HK 21.99 cents
HK 21.21 cents
+3.7%
Total Dividend per Share (Interim + Final)
HK 5.8 cents
HK 5.6 cents
+3.6%